Развитие клеточных и генетических технологий в России

Эффективное здравоохранение

15 января 2020, 11:30 – 13:30, 5 корпус, 5 этаж, Зал заседаний

В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.

Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов. 

Вопросы для обсуждения

  • Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
  • Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.

Модератор

  • Виталий Омельяновский
    Виталий Омельяновский

    генеральный директор Центра экспертизы и контроля качества медицинской помощи Министерства здравоохранения Российской Федерации

Эксперты

  • Игорь Коробко
    Игорь Коробко

    директор Департамента науки, инновационного развития и управления медико- биологическими рисками здоровью Министерства здравоохранения Российской Федерации

  • Вадим Говорун
    Вадим Говорун

    директор Федерального научно-клинического центра физико-химической медицины ФМБА России

  • Этьен Жоусем
    Этьен Жоусем

    руководитель отдела по выводу биомедицинских клеточных продуктов на рынок региона Европа, «Новартис»

  • Михаил Масчан
    Михаил Масчан

    заместитель генерального директора-директор Высшей школы молекулярной и экспериментальной медицины

  • Юрий Жулёв
    Юрий Жулёв

    президент Общероссийской благотворительной общественной организации инвалидов «Всероссийское общество гемофилии»

  • Вадим Меркулов
    Вадим Меркулов

    заместитель генерального директора ФГБУ «НЦЭСМП» Минздрава России по экспертизе лекарственных средств

  • Полина Степенски
    Полина Степенски

    заведующая отделением трансплантации костного мозга и иммунотерапии у детей и взрослых медицинского центра Хадасса, Израиль

  • Сиссель Родаль
    Сиссель Родаль

    генеральный директор по средним европейским странам и России «Авексис»

  • Дмитрий Рождественский
    Дмитрий Рождественский

    начальник отдела координации работ в сфере обращения лекарственных средств и медицинских изделий Департамента технического регулирования и аккредитации ЕЭК

  • Евгений Шляхто
    Евгений Шляхто

    генеральный директор ФГБУ «НМИЦ им. В. А. Алмазова» Министерства здравоохранения Российской Федерации

  • Кэтрин Тэйлор
    Кэтрин Тэйлор

    директор по медицинским вопросам на развивающихся рынках региона EMEA, Янссен

Array
(
    [ACTIVE_TO] => 15.01.2020 13:30:00
    [~ACTIVE_TO] => 15.01.2020 13:30:00
    [ACTIVE_FROM] => 15.01.2020 11:30:00
    [~ACTIVE_FROM] => 15.01.2020 11:30:00
    [ID] => 20567
    [~ID] => 20567
    [NAME] => Развитие клеточных и генетических технологий в России
    [~NAME] => Развитие клеточных и генетических технологий в России
    [IBLOCK_ID] => 9
    [~IBLOCK_ID] => 9
    [IBLOCK_SECTION_ID] => 353
    [~IBLOCK_SECTION_ID] => 353
    [DETAIL_TEXT] => 
    [~DETAIL_TEXT] => 
    [DETAIL_TEXT_TYPE] => html
    [~DETAIL_TEXT_TYPE] => html
    [PREVIEW_TEXT] => 

В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.

Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов. 

[~PREVIEW_TEXT] =>

В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.

Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов. 

[PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [TIMESTAMP_X] => 21.01.2020 12:59:29 [~TIMESTAMP_X] => 21.01.2020 12:59:29 [LIST_PAGE_URL] => /program/ [~LIST_PAGE_URL] => /program/ [DETAIL_PAGE_URL] => /program/15-yanvarya/razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii/ [~DETAIL_PAGE_URL] => /program/15-yanvarya/razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii/ [LANG_DIR] => / [~LANG_DIR] => / [CODE] => razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii [~CODE] => razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii [EXTERNAL_ID] => 20567 [~EXTERNAL_ID] => 20567 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => program [~IBLOCK_CODE] => program [IBLOCK_EXTERNAL_ID] => 9 [~IBLOCK_EXTERNAL_ID] => 9 [LID] => s1 [~LID] => s1 [NAV_RESULT] => [DISPLAY_ACTIVE_FROM] => 15 Января 2020 [IPROPERTY_VALUES] => Array ( ) [FIELDS] => Array ( [ACTIVE_TO] => 15.01.2020 13:30:00 [ACTIVE_FROM] => 15.01.2020 11:30:00 ) [PROPERTIES] => Array ( [QUESTIONS] => Array ( [ID] => 12 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Вопросы для обсуждения [ACTIVE] => Y [SORT] => 10 [CODE] => QUESTIONS [DEFAULT_VALUE] => Array ( [TYPE] => HTML [TEXT] => ) [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 12 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => HTML [USER_TYPE_SETTINGS] => Array ( [height] => 200 ) [HINT] => [PROPERTY_VALUE_ID] => 112126 [VALUE] => Array ( [TEXT] => <ul class="style-prog-list"> <li>Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.</li> <li>Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.</li> </ul> [TYPE] => HTML ) [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [TEXT] =>
  • Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
  • Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
[TYPE] => HTML ) [~DESCRIPTION] => [~NAME] => Вопросы для обсуждения [~DEFAULT_VALUE] => Array ( [TYPE] => HTML [TEXT] => ) ) [TYPE] => Array ( [ID] => 13 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Тип мероприятия [ACTIVE] => Y [SORT] => 20 [CODE] => TYPE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 13 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 138115 [VALUE] => Экспертная дискуссия [DESCRIPTION] => [VALUE_ENUM] => Экспертная дискуссия [VALUE_XML_ID] => 2 [VALUE_SORT] => 200 [VALUE_ENUM_ID] => 2 [~VALUE] => Экспертная дискуссия [~DESCRIPTION] => [~NAME] => Тип мероприятия [~DEFAULT_VALUE] => ) [LOCATION] => Array ( [ID] => 19 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Место проведения мероприятия [ACTIVE] => Y [SORT] => 30 [CODE] => LOCATION [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 19 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 112138 [VALUE] => 5 корпус, 5 этаж, Зал заседаний [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 5 корпус, 5 этаж, Зал заседаний [~DESCRIPTION] => [~NAME] => Место проведения мероприятия [~DEFAULT_VALUE] => ) [MODERATORS] => Array ( [ID] => 14 [TIMESTAMP_X] => 2017-12-18 13:54:45 [IBLOCK_ID] => 9 [NAME] => Модераторы [ACTIVE] => Y [SORT] => 40 [CODE] => MODERATORS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 14 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 112128 ) [VALUE] => Array ( [0] => Array ( [ID] => 15467 [NAME] => Виталий Омельяновский [DETAIL_PAGE_URL] => /experts/vitalij-omelyanovskij5325/ [POSITION] => генеральный директор Центра экспертизы и контроля качества медицинской помощи Министерства здравоохранения Российской Федерации [DONOTLINK] => [PREVIEW_PICTURE] => 36683 ) ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 15467 ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Модераторы [~DEFAULT_VALUE] => ) [KEYREPORTS] => Array ( [ID] => 65 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Ключевой доклад / Ключевые доклады [ACTIVE] => Y [SORT] => 50 [CODE] => KEYREPORTS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 65 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Ключевой доклад / Ключевые доклады [~DEFAULT_VALUE] => ) [KEYREPORT2S] => Array ( [ID] => 283 [TIMESTAMP_X] => 2019-01-04 22:39:47 [IBLOCK_ID] => 9 [NAME] => Ключевые выступления [ACTIVE] => Y [SORT] => 55 [CODE] => KEYREPORT2S [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Ключевые выступления [~DEFAULT_VALUE] => ) [PARTICIPANTS] => Array ( [ID] => 15 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Экcперты [ACTIVE] => Y [SORT] => 60 [CODE] => PARTICIPANTS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 15 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 112129 [1] => 112133 [2] => 112134 [3] => 112137 [4] => 118202 [5] => 118203 [6] => 122637 [7] => 122638 [8] => 122639 [9] => 122640 [10] => 122641 ) [VALUE] => Array ( [0] => Array ( [ID] => 20536 [NAME] => Игорь Коробко [DETAIL_PAGE_URL] => /experts/igor-korobko/ [POSITION] => директор Департамента науки, инновационного развития и управления медико- биологическими рисками здоровью Министерства здравоохранения Российской Федерации [DONOTLINK] => [PREVIEW_PICTURE] => 57417 ) [1] => Array ( [ID] => 20543 [NAME] => Вадим Говорун [DETAIL_PAGE_URL] => /experts/vadim-govorun/ [POSITION] => директор Федерального научно-клинического центра физико-химической медицины ФМБА России [DONOTLINK] => [PREVIEW_PICTURE] => 57416 ) [2] => Array ( [ID] => 20557 [NAME] => Этьен Жоусем [DETAIL_PAGE_URL] => /experts/eten-zhussom/ [POSITION] => руководитель отдела по выводу биомедицинских клеточных продуктов на рынок региона Европа, «Новартис» [DONOTLINK] => [PREVIEW_PICTURE] => ) [3] => Array ( [ID] => 20566 [NAME] => Михаил Масчан [DETAIL_PAGE_URL] => /experts/mikhail-maschan/ [POSITION] => заместитель генерального директора-директор Высшей школы молекулярной и экспериментальной медицины [DONOTLINK] => [PREVIEW_PICTURE] => 57419 ) [4] => Array ( [ID] => 21735 [NAME] => Юрий Жулёв [DETAIL_PAGE_URL] => /experts/yuriy-zhulyev/ [POSITION] => президент Общероссийской благотворительной общественной организации инвалидов «Всероссийское общество гемофилии» [DONOTLINK] => [PREVIEW_PICTURE] => 57574 ) [5] => Array ( [ID] => 21736 [NAME] => Вадим Меркулов [DETAIL_PAGE_URL] => /experts/vadim-merkulov/ [POSITION] => заместитель генерального директора ФГБУ «НЦЭСМП» Минздрава России по экспертизе лекарственных средств [DONOTLINK] => [PREVIEW_PICTURE] => 57420 ) [6] => Array ( [ID] => 21737 [NAME] => Полина Степенски [DETAIL_PAGE_URL] => /experts/polina-stepenski/ [POSITION] => заведующая отделением трансплантации костного мозга и иммунотерапии у детей и взрослых медицинского центра Хадасса, Израиль [DONOTLINK] => [PREVIEW_PICTURE] => ) [7] => Array ( [ID] => 21738 [NAME] => Сиссель Родаль [DETAIL_PAGE_URL] => /experts/sissel-rodal/ [POSITION] => генеральный директор по средним европейским странам и России «Авексис» [DONOTLINK] => [PREVIEW_PICTURE] => ) [8] => Array ( [ID] => 21739 [NAME] => Дмитрий Рождественский [DETAIL_PAGE_URL] => /experts/dmitriy-rozhdestvenskiy/ [POSITION] => начальник отдела координации работ в сфере обращения лекарственных средств и медицинских изделий Департамента технического регулирования и аккредитации ЕЭК [DONOTLINK] => [PREVIEW_PICTURE] => 57421 ) [9] => Array ( [ID] => 15473 [NAME] => Евгений Шляхто [DETAIL_PAGE_URL] => /experts/evgeniy-shlyakhto4021/ [POSITION] => генеральный директор ФГБУ «НМИЦ им. В. А. Алмазова» Министерства здравоохранения Российской Федерации [DONOTLINK] => [PREVIEW_PICTURE] => 36202 ) [10] => Array ( [ID] => 22172 [NAME] => Кэтрин Тэйлор [DETAIL_PAGE_URL] => /experts/ketrin-teylor/ [POSITION] => директор по медицинским вопросам на развивающихся рынках региона EMEA, Янссен [DONOTLINK] => [PREVIEW_PICTURE] => ) ) [DESCRIPTION] => Array ( [0] => [1] => [2] => [3] => [4] => [5] => [6] => [7] => [8] => [9] => [10] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 20536 [1] => 20543 [2] => 20557 [3] => 20566 [4] => 21735 [5] => 21736 [6] => 21737 [7] => 21738 [8] => 21739 [9] => 15473 [10] => 22172 ) [~DESCRIPTION] => Array ( [0] => [1] => [2] => [3] => [4] => [5] => [6] => [7] => [8] => [9] => [10] => ) [~NAME] => Экcперты [~DEFAULT_VALUE] => ) [MEMBERS] => Array ( [ID] => 66 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Участники [ACTIVE] => Y [SORT] => 70 [CODE] => MEMBERS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 66 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Участники [~DEFAULT_VALUE] => ) [MEMBERS_AND_EXPERTS] => Array ( [ID] => 71 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Участники и эксперты [ACTIVE] => Y [SORT] => 80 [CODE] => MEMBERS_AND_EXPERTS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 71 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Участники и эксперты [~DEFAULT_VALUE] => ) [KEYREPORT_MODERATOR] => Array ( [ID] => 73 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Ключевой доклад / модератор [ACTIVE] => Y [SORT] => 90 [CODE] => KEYREPORT_MODERATOR [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 73 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Ключевой доклад / модератор [~DEFAULT_VALUE] => ) [SAY_HIS] => Array ( [ID] => 245 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Приветствие [ACTIVE] => Y [SORT] => 91 [CODE] => SAY_HIS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 245 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Приветствие [~DEFAULT_VALUE] => ) [SPEECH] => Array ( [ID] => 77 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Выступления [ACTIVE] => Y [SORT] => 100 [CODE] => SPEECH [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 77 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Выступления [~DEFAULT_VALUE] => ) [DISCUSS_MEMBERS] => Array ( [ID] => 219 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Участники дискуссии [ACTIVE] => Y [SORT] => 101 [CODE] => DISCUSS_MEMBERS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 219 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Участники дискуссии [~DEFAULT_VALUE] => ) [AUTHORS] => Array ( [ID] => 220 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Авторы [ACTIVE] => Y [SORT] => 102 [CODE] => AUTHORS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 220 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Авторы [~DEFAULT_VALUE] => ) [LECTORS] => Array ( [ID] => 221 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Лекторы [ACTIVE] => Y [SORT] => 103 [CODE] => LECTORS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 221 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Лекторы [~DEFAULT_VALUE] => ) [PRESENTATIONS] => Array ( [ID] => 217 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Презентация [ACTIVE] => Y [SORT] => 104 [CODE] => PRESENTATIONS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 217 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Презентация [~DEFAULT_VALUE] => ) [SPEAKERS] => Array ( [ID] => 231 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Спикеры [ACTIVE] => Y [SORT] => 105 [CODE] => SPEAKERS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 231 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Спикеры [~DEFAULT_VALUE] => ) [OPENINGS] => Array ( [ID] => 240 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Открытие [ACTIVE] => Y [SORT] => 106 [CODE] => OPENINGS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 240 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Открытие [~DEFAULT_VALUE] => ) [SUBTITLE] => Array ( [ID] => 75 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Подзаголовок [ACTIVE] => Y [SORT] => 110 [CODE] => SUBTITLE [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 75 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 112139 [VALUE] => Эффективное здравоохранение [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Эффективное здравоохранение [~DESCRIPTION] => [~NAME] => Подзаголовок [~DEFAULT_VALUE] => ) [MSP_REPRESENTATIVES] => Array ( [ID] => 76 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Представители МСП [ACTIVE] => Y [SORT] => 120 [CODE] => MSP_REPRESENTATIVES [DEFAULT_VALUE] => Array ( [TYPE] => HTML [TEXT] => ) [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 76 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => HTML [USER_TYPE_SETTINGS] => Array ( [height] => 200 ) [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Представители МСП [~DEFAULT_VALUE] => Array ( [TYPE] => HTML [TEXT] => ) ) [MEDIA_LINK] => Array ( [ID] => 118 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Медиаматериалы [ACTIVE] => Y [SORT] => 130 [CODE] => MEDIA_LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 118 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 29 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 138116 [VALUE] => 24286 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 24286 [~DESCRIPTION] => [~NAME] => Медиаматериалы [~DEFAULT_VALUE] => ) [CALENDAR] => Array ( [ID] => 128 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Календарь [ACTIVE] => Y [SORT] => 140 [CODE] => CALENDAR [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 128 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Календарь [~DEFAULT_VALUE] => ) [EVENT_INFO] => Array ( [ID] => 129 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Информационное событие [ACTIVE] => Y [SORT] => 150 [CODE] => EVENT_INFO [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 129 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Информационное событие [~DEFAULT_VALUE] => ) [CHANGE] => Array ( [ID] => 130 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Изменение [ACTIVE] => Y [SORT] => 160 [CODE] => CHANGE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 130 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Изменение [~DEFAULT_VALUE] => ) [LANGUAGES] => Array ( [ID] => 222 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Рабочие языки [ACTIVE] => Y [SORT] => 170 [CODE] => LANGUAGES [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 222 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 138117 [1] => 138118 ) [VALUE] => Array ( [0] => русский [1] => английский ) [DESCRIPTION] => Array ( [0] => [1] => ) [VALUE_ENUM] => Array ( [0] => русский [1] => английский ) [VALUE_XML_ID] => Array ( [0] => 1 [1] => 3 ) [VALUE_SORT] => Array ( [0] => 10 [1] => 30 ) [VALUE_ENUM_ID] => Array ( [0] => 50 [1] => 52 ) [~VALUE] => Array ( [0] => русский [1] => английский ) [~DESCRIPTION] => Array ( [0] => [1] => ) [~NAME] => Рабочие языки [~DEFAULT_VALUE] => ) [INVITATION_ONLY] => Array ( [ID] => 223 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Вход по индивидуальным приглашениям [ACTIVE] => Y [SORT] => 180 [CODE] => INVITATION_ONLY [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 223 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Вход по индивидуальным приглашениям [~DEFAULT_VALUE] => ) [PREMIUM_ONLY] => Array ( [ID] => 232 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Вход с бэйджами категории «ПРЕМИУМ» [ACTIVE] => Y [SORT] => 500 [CODE] => PREMIUM_ONLY [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => N [XML_ID] => 232 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE_ENUM_ID] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Вход с бэйджами категории «ПРЕМИУМ» [~DEFAULT_VALUE] => ) [KEYNOTE_FILE] => Array ( [ID] => 234 [TIMESTAMP_X] => 2019-01-14 21:27:15 [IBLOCK_ID] => 9 [NAME] => Доклад [ACTIVE] => Y [SORT] => 500 [CODE] => KEYNOTE_FILE [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 234 [FILE_TYPE] => pdf [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Доклад [~DEFAULT_VALUE] => ) [EVENT_CATEGORY] => Array ( [ID] => 297 [TIMESTAMP_X] => 2019-12-22 15:15:18 [IBLOCK_ID] => 9 [NAME] => Категория мероприятия [ACTIVE] => Y [SORT] => 500 [CODE] => EVENT_CATEGORY [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 138120 [VALUE] => Научно-экспертная программа [DESCRIPTION] => [VALUE_ENUM] => Научно-экспертная программа [VALUE_XML_ID] => #7fa6cb,#333333 [VALUE_SORT] => 200 [VALUE_ENUM_ID] => 88 [~VALUE] => Научно-экспертная программа [~DESCRIPTION] => [~NAME] => Категория мероприятия [~DEFAULT_VALUE] => ) ) [DISPLAY_PROPERTIES] => Array ( [QUESTIONS] => Array ( [ID] => 12 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Вопросы для обсуждения [ACTIVE] => Y [SORT] => 10 [CODE] => QUESTIONS [DEFAULT_VALUE] => Array ( [TYPE] => HTML [TEXT] => ) [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 12 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => HTML [USER_TYPE_SETTINGS] => Array ( [height] => 200 ) [HINT] => [PROPERTY_VALUE_ID] => 112126 [VALUE] => Array ( [TEXT] => <ul class="style-prog-list"> <li>Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.</li> <li>Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.</li> </ul> [TYPE] => HTML ) [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [TEXT] =>
  • Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
  • Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
[TYPE] => HTML ) [~DESCRIPTION] => [~NAME] => Вопросы для обсуждения [~DEFAULT_VALUE] => Array ( [TYPE] => HTML [TEXT] => ) [DISPLAY_VALUE] =>
  • Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
  • Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
) [LOCATION] => Array ( [ID] => 19 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Место проведения мероприятия [ACTIVE] => Y [SORT] => 30 [CODE] => LOCATION [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 19 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 112138 [VALUE] => 5 корпус, 5 этаж, Зал заседаний [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => 5 корпус, 5 этаж, Зал заседаний [~DESCRIPTION] => [~NAME] => Место проведения мероприятия [~DEFAULT_VALUE] => [DISPLAY_VALUE] => 5 корпус, 5 этаж, Зал заседаний ) [MODERATORS] => Array ( [ID] => 14 [TIMESTAMP_X] => 2017-12-18 13:54:45 [IBLOCK_ID] => 9 [NAME] => Модераторы [ACTIVE] => Y [SORT] => 40 [CODE] => MODERATORS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 14 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 112128 ) [VALUE] => Array ( [0] => 15467 ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 15467 ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Модераторы [~DEFAULT_VALUE] => [DISPLAY_VALUE] => Виталий Омельяновский [LINK_ELEMENT_VALUE] => Array ( [15467] => Array ( [ID] => 15467 [~ID] => 15467 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Виталий Омельяновский [~NAME] => Виталий Омельяновский [DETAIL_PAGE_URL] => /experts/vitalij-omelyanovskij5325/ [~DETAIL_PAGE_URL] => /experts/vitalij-omelyanovskij5325/ [PREVIEW_PICTURE] => 36683 [~PREVIEW_PICTURE] => 36683 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => vitalij-omelyanovskij5325 [~CODE] => vitalij-omelyanovskij5325 [EXTERNAL_ID] => 1000 [~EXTERNAL_ID] => 1000 [IBLOCK_SECTION_ID] => 247 [~IBLOCK_SECTION_ID] => 247 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) ) ) [PARTICIPANTS] => Array ( [ID] => 15 [TIMESTAMP_X] => 2017-12-18 10:54:36 [IBLOCK_ID] => 9 [NAME] => Экcперты [ACTIVE] => Y [SORT] => 60 [CODE] => PARTICIPANTS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 15 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 8 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 112129 [1] => 112133 [2] => 112134 [3] => 112137 [4] => 118202 [5] => 118203 [6] => 122637 [7] => 122638 [8] => 122639 [9] => 122640 [10] => 122641 ) [VALUE] => Array ( [0] => 20536 [1] => 20543 [2] => 20557 [3] => 20566 [4] => 21735 [5] => 21736 [6] => 21737 [7] => 21738 [8] => 21739 [9] => 15473 [10] => 22172 ) [DESCRIPTION] => Array ( [0] => [1] => [2] => [3] => [4] => [5] => [6] => [7] => [8] => [9] => [10] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 20536 [1] => 20543 [2] => 20557 [3] => 20566 [4] => 21735 [5] => 21736 [6] => 21737 [7] => 21738 [8] => 21739 [9] => 15473 [10] => 22172 ) [~DESCRIPTION] => Array ( [0] => [1] => [2] => [3] => [4] => [5] => [6] => [7] => [8] => [9] => [10] => ) [~NAME] => Экcперты [~DEFAULT_VALUE] => [DISPLAY_VALUE] => Array ( [0] => Игорь Коробко [1] => Вадим Говорун [2] => Этьен Жоусем [3] => Михаил Масчан [4] => Юрий Жулёв [5] => Вадим Меркулов [6] => Полина Степенски [7] => Сиссель Родаль [8] => Дмитрий Рождественский [9] => Евгений Шляхто [10] => Кэтрин Тэйлор ) [LINK_ELEMENT_VALUE] => Array ( [20536] => Array ( [ID] => 20536 [~ID] => 20536 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Игорь Коробко [~NAME] => Игорь Коробко [DETAIL_PAGE_URL] => /experts/igor-korobko/ [~DETAIL_PAGE_URL] => /experts/igor-korobko/ [PREVIEW_PICTURE] => 57417 [~PREVIEW_PICTURE] => 57417 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => igor-korobko [~CODE] => igor-korobko [EXTERNAL_ID] => 20536 [~EXTERNAL_ID] => 20536 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [20543] => Array ( [ID] => 20543 [~ID] => 20543 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Вадим Говорун [~NAME] => Вадим Говорун [DETAIL_PAGE_URL] => /experts/vadim-govorun/ [~DETAIL_PAGE_URL] => /experts/vadim-govorun/ [PREVIEW_PICTURE] => 57416 [~PREVIEW_PICTURE] => 57416 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => vadim-govorun [~CODE] => vadim-govorun [EXTERNAL_ID] => 20543 [~EXTERNAL_ID] => 20543 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [20557] => Array ( [ID] => 20557 [~ID] => 20557 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Этьен Жоусем [~NAME] => Этьен Жоусем [DETAIL_PAGE_URL] => /experts/eten-zhussom/ [~DETAIL_PAGE_URL] => /experts/eten-zhussom/ [PREVIEW_PICTURE] => [~PREVIEW_PICTURE] => [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => eten-zhussom [~CODE] => eten-zhussom [EXTERNAL_ID] => 20557 [~EXTERNAL_ID] => 20557 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [20566] => Array ( [ID] => 20566 [~ID] => 20566 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Михаил Масчан [~NAME] => Михаил Масчан [DETAIL_PAGE_URL] => /experts/mikhail-maschan/ [~DETAIL_PAGE_URL] => /experts/mikhail-maschan/ [PREVIEW_PICTURE] => 57419 [~PREVIEW_PICTURE] => 57419 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => mikhail-maschan [~CODE] => mikhail-maschan [EXTERNAL_ID] => 20566 [~EXTERNAL_ID] => 20566 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [21735] => Array ( [ID] => 21735 [~ID] => 21735 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Юрий Жулёв [~NAME] => Юрий Жулёв [DETAIL_PAGE_URL] => /experts/yuriy-zhulyev/ [~DETAIL_PAGE_URL] => /experts/yuriy-zhulyev/ [PREVIEW_PICTURE] => 57574 [~PREVIEW_PICTURE] => 57574 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => yuriy-zhulyev [~CODE] => yuriy-zhulyev [EXTERNAL_ID] => 21735 [~EXTERNAL_ID] => 21735 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [21736] => Array ( [ID] => 21736 [~ID] => 21736 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Вадим Меркулов [~NAME] => Вадим Меркулов [DETAIL_PAGE_URL] => /experts/vadim-merkulov/ [~DETAIL_PAGE_URL] => /experts/vadim-merkulov/ [PREVIEW_PICTURE] => 57420 [~PREVIEW_PICTURE] => 57420 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => vadim-merkulov [~CODE] => vadim-merkulov [EXTERNAL_ID] => 21736 [~EXTERNAL_ID] => 21736 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [21737] => Array ( [ID] => 21737 [~ID] => 21737 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Полина Степенски [~NAME] => Полина Степенски [DETAIL_PAGE_URL] => /experts/polina-stepenski/ [~DETAIL_PAGE_URL] => /experts/polina-stepenski/ [PREVIEW_PICTURE] => [~PREVIEW_PICTURE] => [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => polina-stepenski [~CODE] => polina-stepenski [EXTERNAL_ID] => 21737 [~EXTERNAL_ID] => 21737 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [21738] => Array ( [ID] => 21738 [~ID] => 21738 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Сиссель Родаль [~NAME] => Сиссель Родаль [DETAIL_PAGE_URL] => /experts/sissel-rodal/ [~DETAIL_PAGE_URL] => /experts/sissel-rodal/ [PREVIEW_PICTURE] => [~PREVIEW_PICTURE] => [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => sissel-rodal [~CODE] => sissel-rodal [EXTERNAL_ID] => 21738 [~EXTERNAL_ID] => 21738 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [21739] => Array ( [ID] => 21739 [~ID] => 21739 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Дмитрий Рождественский [~NAME] => Дмитрий Рождественский [DETAIL_PAGE_URL] => /experts/dmitriy-rozhdestvenskiy/ [~DETAIL_PAGE_URL] => /experts/dmitriy-rozhdestvenskiy/ [PREVIEW_PICTURE] => 57421 [~PREVIEW_PICTURE] => 57421 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => dmitriy-rozhdestvenskiy [~CODE] => dmitriy-rozhdestvenskiy [EXTERNAL_ID] => 21739 [~EXTERNAL_ID] => 21739 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [15473] => Array ( [ID] => 15473 [~ID] => 15473 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Евгений Шляхто [~NAME] => Евгений Шляхто [DETAIL_PAGE_URL] => /experts/evgeniy-shlyakhto4021/ [~DETAIL_PAGE_URL] => /experts/evgeniy-shlyakhto4021/ [PREVIEW_PICTURE] => 36202 [~PREVIEW_PICTURE] => 36202 [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => evgeniy-shlyakhto4021 [~CODE] => evgeniy-shlyakhto4021 [EXTERNAL_ID] => 2214 [~EXTERNAL_ID] => 2214 [IBLOCK_SECTION_ID] => 247 [~IBLOCK_SECTION_ID] => 247 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) [22172] => Array ( [ID] => 22172 [~ID] => 22172 [IBLOCK_ID] => 8 [~IBLOCK_ID] => 8 [NAME] => Кэтрин Тэйлор [~NAME] => Кэтрин Тэйлор [DETAIL_PAGE_URL] => /experts/ketrin-teylor/ [~DETAIL_PAGE_URL] => /experts/ketrin-teylor/ [PREVIEW_PICTURE] => [~PREVIEW_PICTURE] => [DETAIL_PICTURE] => [~DETAIL_PICTURE] => [SORT] => 500 [~SORT] => 500 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => ketrin-teylor [~CODE] => ketrin-teylor [EXTERNAL_ID] => 22172 [~EXTERNAL_ID] => 22172 [IBLOCK_SECTION_ID] => 346 [~IBLOCK_SECTION_ID] => 346 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [IBLOCK_CODE] => experts [~IBLOCK_CODE] => experts [IBLOCK_EXTERNAL_ID] => 8 [~IBLOCK_EXTERNAL_ID] => 8 [LID] => s1 [~LID] => s1 ) ) ) [SUBTITLE] => Array ( [ID] => 75 [TIMESTAMP_X] => 2018-12-13 12:17:20 [IBLOCK_ID] => 9 [NAME] => Подзаголовок [ACTIVE] => Y [SORT] => 110 [CODE] => SUBTITLE [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 75 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 112139 [VALUE] => Эффективное здравоохранение [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Эффективное здравоохранение [~DESCRIPTION] => [~NAME] => Подзаголовок [~DEFAULT_VALUE] => [DISPLAY_VALUE] => Эффективное здравоохранение ) ) [IBLOCK] => Array ( [ID] => 9 [~ID] => 9 [TIMESTAMP_X] => 16.01.2020 11:03:48 [~TIMESTAMP_X] => 16.01.2020 11:03:48 [IBLOCK_TYPE_ID] => content [~IBLOCK_TYPE_ID] => content [LID] => s1 [~LID] => s1 [CODE] => program [~CODE] => program [NAME] => Программа форума [~NAME] => Программа форума [ACTIVE] => Y [~ACTIVE] => Y [SORT] => 90 [~SORT] => 90 [LIST_PAGE_URL] => /program/ [~LIST_PAGE_URL] => /program/ [DETAIL_PAGE_URL] => #SITE_DIR#/program/#SECTION_CODE_PATH#/#ELEMENT_CODE#/ [~DETAIL_PAGE_URL] => #SITE_DIR#/program/#SECTION_CODE_PATH#/#ELEMENT_CODE#/ [SECTION_PAGE_URL] => #SITE_DIR#/program/#SECTION_CODE_PATH#/ [~SECTION_PAGE_URL] => #SITE_DIR#/program/#SECTION_CODE_PATH#/ [CANONICAL_PAGE_URL] => [~CANONICAL_PAGE_URL] => [PICTURE] => [~PICTURE] => [DESCRIPTION] => [~DESCRIPTION] => [DESCRIPTION_TYPE] => text [~DESCRIPTION_TYPE] => text [RSS_TTL] => 24 [~RSS_TTL] => 24 [RSS_ACTIVE] => Y [~RSS_ACTIVE] => Y [RSS_FILE_ACTIVE] => N [~RSS_FILE_ACTIVE] => N [RSS_FILE_LIMIT] => [~RSS_FILE_LIMIT] => [RSS_FILE_DAYS] => [~RSS_FILE_DAYS] => [RSS_YANDEX_ACTIVE] => N [~RSS_YANDEX_ACTIVE] => N [XML_ID] => 9 [~XML_ID] => 9 [TMP_ID] => 2b02f4b9c40625a89488a3a5fd78a273 [~TMP_ID] => 2b02f4b9c40625a89488a3a5fd78a273 [INDEX_ELEMENT] => Y [~INDEX_ELEMENT] => Y [INDEX_SECTION] => Y [~INDEX_SECTION] => Y [WORKFLOW] => N [~WORKFLOW] => N [BIZPROC] => N [~BIZPROC] => N [SECTION_CHOOSER] => L [~SECTION_CHOOSER] => L [LIST_MODE] => C [~LIST_MODE] => C [RIGHTS_MODE] => S [~RIGHTS_MODE] => S [SECTION_PROPERTY] => N [~SECTION_PROPERTY] => N [PROPERTY_INDEX] => N [~PROPERTY_INDEX] => N [VERSION] => 1 [~VERSION] => 1 [LAST_CONV_ELEMENT] => 0 [~LAST_CONV_ELEMENT] => 0 [SOCNET_GROUP_ID] => [~SOCNET_GROUP_ID] => [EDIT_FILE_BEFORE] => [~EDIT_FILE_BEFORE] => [EDIT_FILE_AFTER] => [~EDIT_FILE_AFTER] => [SECTIONS_NAME] => Разделы [~SECTIONS_NAME] => Разделы [SECTION_NAME] => Раздел [~SECTION_NAME] => Раздел [ELEMENTS_NAME] => Элементы [~ELEMENTS_NAME] => Элементы [ELEMENT_NAME] => Элемент [~ELEMENT_NAME] => Элемент [EXTERNAL_ID] => 9 [~EXTERNAL_ID] => 9 [LANG_DIR] => / [~LANG_DIR] => / [SERVER_NAME] => gaidarforum.ru [~SERVER_NAME] => gaidarforum.ru ) [SECTION] => Array ( [PATH] => Array ( ) ) [SECTION_URL] => [META_TAGS] => Array ( [TITLE] => Развитие клеточных и генетических технологий в России [ELEMENT_CHAIN] => Развитие клеточных и генетических технологий в России [BROWSER_TITLE] => [KEYWORDS] => [DESCRIPTION] => ) [EXPERTSTYPES] => Array ( [0] => OPENINGS [1] => SAY_HIS [2] => MODERATORS [3] => KEYREPORT_MODERATOR [4] => KEYREPORTS [5] => KEYREPORT2S [6] => SPEAKERS [7] => SPEECH [8] => PRESENTATIONS [9] => MEMBERS [10] => PARTICIPANTS [11] => MEMBERS_AND_EXPERTS [12] => DISCUSS_MEMBERS [13] => AUTHORS [14] => LECTORS ) [DATE_EVENT] => 15 января 2020 [START_TIME] => 11:30 [END_TIME] => 13:30 [TIME_EVENT] => 15 января [OGDESC] =>

В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.

Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов. 

)